SEC Form 3 · accession 0001704673-17-000002
CLEVELAND BIOLABS INC · CBLI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Edward Szydlo
Officer — Principal Financial Officer
Period of report
Apr 21, 2017
Accepted (ET)
May 1, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001318641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 273 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $26.00 | holding | — | — | — | — | May 30, 2022 | Common Stock | 250 | — | D |
| Employee Stock Option (right to buy)F1 | $25.60 | holding | — | — | — | — | Nov 13, 2022 | Common Stock | 34 | — | D |
| Employee Stock Option (right to buy)F1 | $30.80 | holding | — | — | — | — | May 13, 2023 | Common Stock | 250 | — | D |
| Employee Stock Option (right to buy)F1 | $13.60 | holding | — | — | — | — | Mar 13, 2024 | Common Stock | 1,200 | — | D |
| Employee Stock Option (right to buy)F1 | $3.20 | holding | — | — | — | — | Apr 22, 2025 | Common Stock | 1,200 | — | D |
Explanation of responses
- F1The holder of this security may exercise it at any time.